Business
‘Not of use for much’: Hospitals told not to give remdesivir to COVID-19 patients – Sydney Morning Herald
The medication was one of the drugs used to treat US President Donald Trump’s coronavirus infection.
The antiviral, known by the brand name Veklury, is one of only two medicines currently authorised to treat COVID-19 patients across the world. But a large WHO-led test known as the Solidarity Trial showed last month that it had little or no effect on 28-day mortality or length of hospital stays for COVID-19 patients.
The medication was one of the drugs used to treat US President Donald Trump’s coronavirus infection, and had been shown in previous studies to have cut time to recovery. It is authorised…
-
Noosa News14 hours agoWilliam Robinson dies aged 89
-
Business18 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Business18 hours agoWhat to do with these 3 ASX 200 retail shares after strong price runs: experts
-
General14 hours agoCalls for corruption probe into completion of mayor’s Surfers Paradise Bowls Club site purchase